Regeneron starts Phase 3 antibody testing as coronavirus cases surge

Just days after it pulled the plug on its rheumatoid arthritis drug to treat COVID-19, biotech company Regeneron said on Monday it was starting Phase III of its double-antibody treatment for the novel coronavirus.

from FOX News https://ift.tt/3gq3Aiu
v